N-Ethylheptylone
![]()  | |
| Identifiers | |
|---|---|
  | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H23NO3 | 
| Molar mass | 277.364 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
N-Ethylheptylone (HEP) is a recreational designer drug from the substituted cathinone family, with stimulant effects. It is a homologue of related drugs such as ethylone, eutylone, ephylone and N-ethylhexylone but with a longer pentyl side chain. It was first reported in Sweden in 2019.[1]
See also
References
- ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
 
